Halozyme Therapeutics shares owned by Davidson Kempner Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Davidson Kempner Capital Management
from 13F filings
Historical chart of Davidson Kempner Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Davidson Kempner Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $43M | 50M | 0.86 |
| 2023-09-30 | $42M | 50M | 0.84 |
| 2023-06-30 | $43M | 52M | 0.83 |
| 2023-03-31 | $56M | 67M | 0.85 |
| 2022-12-31 | $77M | 79M | 0.97 |
| 2022-09-30 | $67M | 79M | 0.85 |
| 2022-06-30 | $61M | 69M | 0.88 |
| 2022-03-31 | $56M | 65M | 0.87 |
More positions owned by Davidson Kempner Capital Management
View all positions for Davidson Kempner Capital Management